• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanistic analysis of Azithromycin

June 19, 2020COVID-19, Vizit Graphs
Mechanistic analysis of AzithromycinEftychia Lekka2020-08-03T14:35:12+00:00
Mechanistic analysis of Azithromycin

Azithromycin is being tested in COVID-19 patients. Although it is a potent antibiotic, in the COVID-19 setting, it likely acts as an anti-inflammatory agent. Its exact MoA in the disease, however, remains to be elucidated.

Explore the live graph.

Tags: ACE, ACE2, ANGIOTENSIN II, AZITHROMYCIN, CALCA, CD4, IFNG, IL10, IL1B, IL6, IL8, INTERFERON, RAS, SARS-COV-2, SPIKE, TMPRSS2, TNF

Post navigation

← Mechanistic analysis of Tocilizumab
Lopinavir/Ritonavir mechanism of action analysis in COVID-19 →

Vizit Graphs Tag Cloud

APOPTOTIC PROCESS STAPHYLOCOCCUS AUREUS NEUTROPHILS RHEUMATOID ARTHRITIS INFLAMMATION CANCER METFORMIN CASP3 IL1B CELL PROLIFERATION ACE NFKB1 ACE2 HELICOBACTER PYLORI COAGULATION ANGIOTENSIN II INSULIN CANDIDA ALBICANS TMPRSS2 INTERFERON LISTERIA MONOCYTOGENES LACTATE DEHYDROGENASE SARS-COV-2 IFNG CELL DIFFERENTIATION IMMUNE RESPONSE PSEUDOMONAS AERUGINOSA AGING MYALGIA PD-1 IL10 RAS IL6 INFLAMMATORY RESPONSE ALBUMIN AUTOPHAGY TNF ESCHERICHIA COLI COVID-19 PARKINSON DISEASE COGNITION ALZHEIMER'S DISEASE IMMUNITY IL2 CD4

© 2021 Biovista Vizit All Rights Reserved.